Net Margin - Mabwell Shanghai Bioscience Co Ltd (SSE:688062) - Alpha Spread
M

Mabwell Shanghai Bioscience Co Ltd
SSE:688062

Watchlist Manager
Mabwell Shanghai Bioscience Co Ltd
SSE:688062
Watchlist
Price: 21.24 CNY -0.28% Market Closed
Market Cap: 8.5B CNY
Have any thoughts about
Mabwell Shanghai Bioscience Co Ltd?
Write Note

Net Margin
Mabwell Shanghai Bioscience Co Ltd

-532%
Current
-4 124%
Average
-7.7%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-532%
=
Net Income
-1B
/
Revenue
191.4m

Net Margin Across Competitors

Country CN
Market Cap 8.5B CNY
Net Margin
-532%
Country US
Market Cap 340.3B USD
Net Margin
10%
Country US
Market Cap 181.1B USD
Net Margin
10%
Country US
Market Cap 129.3B USD
Net Margin
32%
Country US
Market Cap 123.8B USD
Net Margin
-5%
Country US
Market Cap 94.1B EUR
Net Margin
-392%
Country US
Market Cap 104.7B USD
Net Margin
4%
Country AU
Market Cap 142.3B AUD
Net Margin
18%
Country US
Market Cap 39.3B EUR
Net Margin
-33%
Country US
Market Cap 38.2B USD
Net Margin
-557%
Country US
Market Cap 35.7B USD
Net Margin
-3%

Profitability Report

View the profitability report to see the full profitability analysis for Mabwell Shanghai Bioscience Co Ltd.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-532%
=
Net Income
-1B
/
Revenue
191.4m
What is the Net Margin of Mabwell Shanghai Bioscience Co Ltd?

Based on Mabwell Shanghai Bioscience Co Ltd's most recent financial statements, the company has Net Margin of -532%.